Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma
We present a case report of a male with multifocal and extensive basal cell carcinoma. Due to extremely large size and deep tumor infiltration, he was not a surgical candidate. Combined modality treatment of fractionated radiation with concurrent vismodegib was chosen. Concurrent treatment was previ...
Saved in:
Main Authors: | Abigail I. Franco (Author), Gary Eastwick (Author), Ramsay Farah (Author), Marvin Heyboer (Author), Mijung Lee (Author), Paul Aridgides (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011) -
[Translated article] Multimodal Therapy With Vismodegib and Radiotherapy in the Treatment of Locally Advanced Basal Cell Carcinoma: A Series of 4 Cases
by: L. Pulido Prieto, et al.
Published: (2023) -
Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)
by: Federico Venturi, et al.
Published: (2023) -
Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
by: Batty N, et al.
Published: (2012) -
Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
by: Pedro Carvalho Martins, et al.
Published: (2019)